Precision Biosciences Inc financial data

Symbol
DTIL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
302 East Pettigrew Street, Suite A 100, Durham, NC
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 547 % +86.2%
Debt-to-equity 175 % -63.8%
Return On Equity 12.3 %
Return On Assets 4.48 %
Operating Margin -38.1 % +57.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.5M shares +51.6%
Common Stock, Shares, Outstanding 8.2M shares +97%
Entity Public Float 66.8M USD +13%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 6.83M shares +77.9%
Weighted Average Number of Shares Outstanding, Diluted 6.88M shares +79.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 68.7M USD +41%
Research and Development Expense 59.6M USD +11.6%
General and Administrative Expense 35.3M USD -9.69%
Operating Income (Loss) -26.2M USD +40.2%
Net Income (Loss) Attributable to Parent 7.17M USD -8.94%
Earnings Per Share, Basic 1.05 USD/shares +22.1%
Earnings Per Share, Diluted 1.04 USD/shares +22.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 85.9M USD -26.4%
Marketable Securities, Current 413K USD
Accounts Receivable, after Allowance for Credit Loss, Current 229K USD -74.6%
Other Assets, Current 369K USD -11.9%
Assets, Current 95M USD -30.3%
Deferred Income Tax Assets, Net 2.11M USD -35.6%
Property, Plant and Equipment, Net 3.09M USD -51.3%
Operating Lease, Right-of-Use Asset 7.09M USD -14.2%
Intangible Assets, Net (Excluding Goodwill) 622K USD +55.5%
Other Assets, Noncurrent 221K USD -1.78%
Assets 136M USD -14.6%
Accounts Payable, Current 1.31M USD -55.8%
Employee-related Liabilities, Current 5.18M USD +4.1%
Contract with Customer, Liability, Current 2.96M USD -75.4%
Liabilities, Current 15M USD -70%
Contract with Customer, Liability, Noncurrent 23.3M USD -68.1%
Deferred Income Tax Liabilities, Net 2.11M USD -35.6%
Operating Lease, Liability, Noncurrent 6.4M USD -17.1%
Other Liabilities, Noncurrent 194K USD +51.6%
Liabilities 80M USD -43.2%
Retained Earnings (Accumulated Deficit) -482M USD +1.46%
Stockholders' Equity Attributable to Parent 56.4M USD +199%
Liabilities and Equity 136M USD -14.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19M USD +39.7%
Net Cash Provided by (Used in) Financing Activities 40.1M USD +5311%
Net Cash Provided by (Used in) Investing Activities -26K USD +96.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 8.23M shares +96.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21.1M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 108M USD -7.04%
Interest Paid, Excluding Capitalized Interest, Operating Activities 526K USD +13.4%
Deferred Tax Assets, Valuation Allowance 137M USD -1.63%
Operating Lease, Liability 7.72M USD -12.8%
Lessee, Operating Lease, Liability, to be Paid 9.47M USD -16.6%
Property, Plant and Equipment, Gross 31.2M USD -2.08%
Operating Lease, Liability, Current 1.32M USD +16.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.02M USD +2.91%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.96M USD +3.92%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.74M USD -30.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.08M USD +2.92%
Deferred Tax Assets, Operating Loss Carryforwards 51.8M USD +13.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.14M USD +2.98%
Operating Lease, Payments 462K USD -19.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 12.6M USD -10.2%
Interest Expense 1.78M USD -20.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%